|
Title
|
|
|
|
Hepatitis A vaccination and its immunological and epidemiological long-term effects : a review of the evidence
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| Hepatitis A virus (HAV) infections continue to represent a significant disease burden causing approximately 200 million infections, 30 million symptomatic illnesses and 30,000 deaths each year. Effective and safe hepatitis A vaccinfes have been available since the early 1990s. Initially developed for individual prophylaxis, HAV vaccines are now increasingly used to control hepatitis A in endemic areas. The human enteral HAV is eradicable in principle, however, HAV eradication is currently not being pursued. Inactivated HAV vaccines are safe and, after two doses, elicit seroprotection in healthy children, adolescents, and young adults for an estimated 30-40 years, if not lifelong, with no need for a later second booster. The long-term effects of the single-dose live-attenuated HAV vaccines are less well documented but available data suggest they are safe and provide long-lasting immunity and protection. A universal mass vaccination strategy (UMV) based on two doses of inactivated vaccine is commonly implemented in endemic countries and eliminates clinical hepatitis A disease in toddlers within a few years. Consequently, older age groups also benefit due to the herd protection effects. Single-dose UMV programs have shown promising outcomes but need to be monitored for many more years in order to document an effective immune memory persistence. In non-endemic countries, prevention efforts need to focus on 'new' risk groups, such as men having sex with men, prisoners, the homeless, and families visiting friends and relatives in endemic countries. This narrative review presents the current evidence regarding the immunological and epidemiological long-term effects of the hepatitis A vaccination and finally discusses emerging issues and areas for research. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Human vaccines & immunotherapeutics. - Philadelphia, Pa, 2012, currens
| |
|
Publication
|
|
|
|
Philadelphia
:
Taylor & francis inc
,
2021
| |
|
ISSN
|
|
|
|
2164-5515
[print]
2164-554X
[online]
| |
|
DOI
|
|
|
|
10.1080/21645515.2020.1819742
| |
|
Volume/pages
|
|
|
|
17
:5
(2021)
, p. 1496-1519
| |
|
ISI
|
|
|
|
000599412700001
| |
|
Pubmed ID
|
|
|
|
33325760
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|